Home › Blood Disorders › California › San Diego
Blood Disorders clinical trials in San Diego, CA
4 studies for Blood Disorders are looking for participants at sites in and around San Diego (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RecruitingObservational study
- Hemophilia & Thrombosis Treatment Center at UC San Diego Health, San Diego
- Rady Children's Hospital San Diego, San Diego
The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research
RecruitingObservational study
- LabPMM, San Diego
About Blood Disorders
Blood disorders affect one or more parts of the blood and prevent your blood from doing its job. Find out about the types, causes, and treatments.
More about Blood Disorders on MedlinePlus
Blood Disorders trials in other cities
- Atlanta, GA10 studies
- Boston, MA10 studies
- Los Angeles, CA9 studies
- Houston, TX9 studies
- The Bronx, NY8 studies
- Nashville, TN7 studies
- New York City, NY7 studies
- Mountain View, CA6 studies
- Washington, DC5 studies
- Greenville, NC5 studies
- Durham, NC5 studies
- Portland, OR5 studies
Other studies in San Diego
- Non-Small Cell Lung Cancer48 studies
- Breast Cancer41 studies
- Cancer (all types)33 studies
- Prostate Cancer30 studies
- Metastatic Cancer29 studies
- Ovarian Cancer24 studies
- Colorectal Cancer24 studies
- Pancreatic Cancer24 studies
- Heart Failure23 studies
- Lung Cancer23 studies
- Obesity23 studies
- Depression21 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.